drugset / Trial / NCT00526214

Administration of Celecoxib for Treatment of Intracerebral Hemorrhage : A Pilot Study

NCT00526214

Completed 44 enrolled Seoul National University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Primary: Change of volume of perihematomal edema as assessed by brain CT. Secondary: The change of ICH volume between the initial and the follow-up CT scans The neurological status at 90 day using E-GOS and mRS. The cumulative incidence of major and minor adverse events that occurred during and after hospitalization until the end of the study

Timeline

Start
2007-10
Primary completion
2009-05
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 400 mg Oral